OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert LONN.../  DE000ME7WYQ4  /

Stuttgart
2024-04-26  12:00:51 PM Chg.0.00 Bid10:00:35 PM Ask10:00:35 PM Underlying Strike price Expiration date Option type
356.85EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 LONZA N - CHF 2024-06-28 Call
GlobeNewswire 04-04 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire 04-04 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 02-27 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 02-15 Galapagos presents at EBMT-EHA annual meeting 2024
GlobeNewswire 01-04 Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire 2023-12-19 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire 2023-12-09 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 2023-12-07 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 2023-12-07 Business Update
GlobeNewswire 2023-11-06 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-01 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 2023-10-19 Viralgen welcomes back Andy Holt as CCO
GlobeNewswire 2023-10-16 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 2023-10-02 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 2023-09-20 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GlobeNewswire 2023-09-19 Galapagos appoints Simon Sturge to its Board of Directors
GlobeNewswire 2023-09-13 Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
GlobeNewswire 2023-09-07 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire 2023-09-05 Ascendis Pharma Reports Second Quarter 2023 Financial Results
GlobeNewswire 2022-03-14  aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
GlobeNewswire 2022-02-10 Finch Therapeutics Announces Additions to Senior Leadership Team
GlobeNewswire 2022-01-04 Kamran Tahamtanzadeh Joins Inanovate, Inc. as New Chief Executive Officer
GlobeNewswire 2021-11-04 Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
GlobeNewswire 2021-11-02 Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire 2021-10-12 Moderna, VIA and Benchling Receive “Tell Awards” for FDI in Switzerland